Detalles de la búsqueda
1.
Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors.
Diabetologia
; 65(12): 2032-2043, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945333
2.
Differential effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose-response meta-analysis involving 10 randomized clinical trials and 71 553 individuals.
Eur J Endocrinol
; 189(1): S17-S25, 2023 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37474112
Resultados
1 -
2
de 2
1
Próxima >
>>